Information PortalData Portal

Data Matrix

Tools & Workflows

Documentation

Mantle cell lymphoma (Disease or Phenotype)

Description: A disease or phenotype in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Mantle cell lymphoma's neighborhood in the knowledge graph.

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
	Lenalidomide Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Mantle cell lymphoma Disease or Phenotype (Entity type)
	temsirolimus Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Mantle cell lymphoma Disease or Phenotype (Entity type)
	Fludarabine phosphate Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Mantle cell lymphoma Disease or Phenotype (Entity type)
	Zanubrutinib Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Mantle cell lymphoma Disease or Phenotype (Entity type)
	acalabrutinib Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Mantle cell lymphoma Disease or Phenotype (Entity type)
	1,18-Dihydroxy-12-[2-(4-hydroxy-3-methoxy-cyclohexyl)-1-methyl-ethyl]-19,30,33-trimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-aza-tricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone;Rapamycin Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Mantle cell lymphoma Disease or Phenotype (Entity type)
	fludarabine Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Mantle cell lymphoma Disease or Phenotype (Entity type)
	Dipeptidyl boronic acid derivative Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Mantle cell lymphoma Disease or Phenotype (Entity type)
	IBRUTINIB::US9108973, Ref 1::US9181263, 1::US9278100, 1 Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Mantle cell lymphoma Disease or Phenotype (Entity type)

Lenalidomide
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Mantle cell lymphoma
Disease or Phenotype (Entity type)

temsirolimus
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Mantle cell lymphoma
Disease or Phenotype (Entity type)

Fludarabine phosphate
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Mantle cell lymphoma
Disease or Phenotype (Entity type)

Zanubrutinib
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Mantle cell lymphoma
Disease or Phenotype (Entity type)

acalabrutinib
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Mantle cell lymphoma
Disease or Phenotype (Entity type)

1,18-Dihydroxy-12-[2-(4-hydroxy-3-methoxy-cyclohexyl)-1-methyl-ethyl]-19,30,33-trimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-aza-tricyclo[30.3.1.0*4,9*]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone;Rapamycin
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Mantle cell lymphoma
Disease or Phenotype (Entity type)

fludarabine
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Mantle cell lymphoma
Disease or Phenotype (Entity type)

Dipeptidyl boronic acid derivative
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Mantle cell lymphoma
Disease or Phenotype (Entity type)

IBRUTINIB::US9108973, Ref 1::US9181263, 1::US9278100, 1
Compound (Entity type)
Indication
Knowledge Graph Relation (Entity type)
Mantle cell lymphoma
Disease or Phenotype (Entity type)

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025